Please login to the form below

enasidenib

This page shows the latest enasidenib news and features for those working in and with pharma, biotech and healthcare.

Novartis gets EU nod for leukaemia drug Rydapt

or AML with myelodysplasia-related changes (AML-MRC) – while Celgene/Agios claimed approval for Idhifa (enasidenib) as a treatment for AML patients with the IDH2 mutation.

Latest news

Celgene, Agios get FDA OK for leukaemia drug Idhifa

Idhifa ( enasidenib or AG-221) has been cleared for the treatment of relapsed or refractory acute myeloid leukaemia (AML) in patients with an IDH2 mutation, a group that accounts for somewhere ... At Celgene, enasidenib will slot into its blood cancer
Celgene bags US priority review for cancer metabolism drug

Celgene bags US priority review for cancer metabolism drug. First approval for enasidenib could be just six months away. ... Celgene could be just six months away from getting its first approval for enasidenib, a first-in-class drug for acute myeloid

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Client Services Director - Med Comms: Great salary and bebefits

Senior Project Manager - Medical Writing: Great salary and bebefits

Account Manager: £40, 000 - £45, 000 benefits

Editorial Director – Medical Education (MedComms): Neg

Healthcare PR Director: £100, 000 – £120, 000 benefits

Home based, Chief Medical Writer, Medical Communications: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Home based, Principal Medical Writer, Medical Communications: Excellent package

Senior Account Manager: Competitive salary commensurate with experience

Home based, Editorial Team Leader, Medical Communications: Excellent package

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Business Unit Head, Medical Communications, London: Excellent package

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Delivery Manager/ Head of Delivery – Executive Search: Neg

Multi-Channel Account Managers - Road / Homebased – Full or Part...: Competitive salary

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Home based, Senior Medical Writer, Medical Communications: Excellent package

Client Services Director – Healthcare Advertising - London: Neg

Subscribe to our email news alerts

PMHub

Add my company

Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...